BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lago SG, Bahn S. Clinical Trials and Therapeutic Rationale for Drug Repurposing in Schizophrenia. ACS Chem Neurosci 2019;10:58-78. [PMID: 29944339 DOI: 10.1021/acschemneuro.8b00205] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Stephan M, Schoeller J, Raabe FJ, Schmitt A, Hasan A, Falkai P, Jensen N, Rossner MJ. Spironolactone alleviates schizophrenia-related reversal learning in Tcf4 transgenic mice subjected to social defeat. Schizophr 2022;8:77. [DOI: 10.1038/s41537-022-00290-4] [Reference Citation Analysis]
2 Lago SG, Tomasik J, van Rees GF, Rustogi N, Vázquez-Bourgon J, Papiol S, Suarez-Pinilla P, Crespo-Facorro B, Bahn S. Peripheral lymphocyte signaling pathway deficiencies predict treatment response in first-onset drug-naïve schizophrenia. Brain Behav Immun 2022;103:37-49. [PMID: 35381347 DOI: 10.1016/j.bbi.2022.03.016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Mejia-Gutierrez M, Vásquez-Paz BD, Fierro L, Maza JR. In Silico Repositioning of Dopamine Modulators with Possible Application to Schizophrenia: Pharmacophore Mapping, Molecular Docking and Molecular Dynamics Analysis. ACS Omega 2021;6:14748-64. [PMID: 34151057 DOI: 10.1021/acsomega.0c05984] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Lago SG, Tomasik J, Bahn S. Functional patient-derived cellular models for neuropsychiatric drug discovery. Transl Psychiatry 2021;11:128. [PMID: 33597511 DOI: 10.1038/s41398-021-01243-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
5 Lintunen J, Lähteenvuo M, Tiihonen J, Tanskanen A, Taipale H. Adenosine modulators and calcium channel blockers as add-on treatment for schizophrenia. NPJ Schizophr 2021;7:1. [PMID: 33479257 DOI: 10.1038/s41537-020-00135-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 10.0] [Reference Citation Analysis]
6 Lago SG, Tomasik J, van Rees GF, Rubey M, Gonzalez-vioque E, Ramsey JM, Haenisch F, Broek JA, Vázquez-bourgon J, Papiol S, Suarez-pinilla P, Ruland T, Auyeug B, Mikova O, Kabacs N, Arolt V, Baron-cohen S, Crespo-facorro B, Bahn S. Exploring cellular markers of metabolic syndrome in peripheral blood mononuclear cells across the neuropsychiatric spectrum. Brain, Behavior, and Immunity 2021;91:673-82. [DOI: 10.1016/j.bbi.2020.07.043] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
7 Mao X. Drug Repurposing in Neurological Diseases: Opportunities and Challenges. Drug Repurposing - Hypothesis, Molecular Aspects and Therapeutic Applications 2020. [DOI: 10.5772/intechopen.93093] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Hayes JF, Lundin A, Wicks S, Lewis G, Wong ICK, Osborn DPJ, Dalman C. Association of Hydroxylmethyl Glutaryl Coenzyme A Reductase Inhibitors, L-Type Calcium Channel Antagonists, and Biguanides With Rates of Psychiatric Hospitalization and Self-Harm in Individuals With Serious Mental Illness. JAMA Psychiatry 2019;76:382-90. [PMID: 30624557 DOI: 10.1001/jamapsychiatry.2018.3907] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 19.0] [Reference Citation Analysis]
9 Porter JD, Vivas O, Weaver CD, Alsafran A, DiMilo E, Arnold LA, Dickson EJ, Dockendorff C. An anthrone-based Kv7.2/7.3 channel blocker with improved properties for the investigation of psychiatric and neurodegenerative disorders. Bioorg Med Chem Lett 2019;29:126681. [PMID: 31668424 DOI: 10.1016/j.bmcl.2019.126681] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
10 Satish Kumar K, Velayutham R, Roy KK. A systematic computational analysis of human matrix metalloproteinase 13 (MMP-13) crystal structures and structure-based identification of prospective drug candidates as MMP-13 inhibitors repurposable for osteoarthritis. Journal of Biomolecular Structure and Dynamics 2020;38:3074-86. [DOI: 10.1080/07391102.2019.1651221] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]